OVAT Stock Overview
Engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Ovation Science Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.03 |
| 52 Week High | CA$0.055 |
| 52 Week Low | CA$0.01 |
| Beta | 0.26 |
| 11 Month Change | -25.00% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -60.00% |
| 5 Year Change | -85.00% |
| Change since IPO | -93.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| OVAT | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -5.2% | 1.3% |
| 1Y | 0% | -23.4% | 23.1% |
Return vs Industry: OVAT exceeded the Canadian Pharmaceuticals industry which returned -23.4% over the past year.
Return vs Market: OVAT underperformed the Canadian Market which returned 23.1% over the past year.
Price Volatility
| OVAT volatility | |
|---|---|
| OVAT Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: OVAT's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine OVAT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Terry Howlett | ovationscience.com |
Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil.
Ovation Science Inc. Fundamentals Summary
| OVAT fundamental statistics | |
|---|---|
| Market cap | CA$1.06m |
| Earnings (TTM) | -CA$636.99k |
| Revenue (TTM) | CA$101.88k |
10.4x
P/S Ratio-1.7x
P/E RatioIs OVAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OVAT income statement (TTM) | |
|---|---|
| Revenue | CA$101.88k |
| Cost of Revenue | CA$38.64k |
| Gross Profit | CA$63.24k |
| Other Expenses | CA$700.23k |
| Earnings | -CA$636.99k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.018 |
| Gross Margin | 62.07% |
| Net Profit Margin | -625.25% |
| Debt/Equity Ratio | -30.4% |
How did OVAT perform over the long term?
See historical performance and comparison